Buy Deciphera Pharmaceuticals Stock | DCPH Stock Price & Latest News | Public.com
DCPH

Deciphera Pharmaceuticals

$0.00 (0.00%)Today
    View Deciphera Pharmaceuticals (DCPH) stock trends here

    About DCPH

    Deciphera Pharmaceuticals, Inc. engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases th...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.38
    -0.75
    -1.13
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$1.06

    Actual EPS
    Q2 2021

    Stats

    Market Cap$2,7B
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$68.40
    1 Year Low$39.42
    Open$47.00
    High$47.02
    Low$44.41

    Buy any stock with any amount of money.

    Download the App
    Download the app